Background
Erdheim-Chester disease is a rare illness which can present various unusual clinical aspects. It is a histiocytosis characterized by an infiltration of various tissues and organs by spumous histiocytes, without evidence of malignancy. Many different sites can be involved: bones, retroperitoneum, pleuro-pulmonary sites, skin, and central nervous system can be infiltrated as well. Currently, there is no effective therapy. Our case might contribute to an increased awareness of this disease by stressing the skeletal rather than specific aspects of the condition.
Case Report
This 56-year-old woman was admitted for difficulties with walking and several falls. She had been well until 4 weeks earlier when she noticed a progressively increasing unsteady gait and a slurred speech.
The patient had no significant medical or surgical history except for the diagnosis of a "mesenteric panniculitis" 8 years before. The lesion was not resectable, as shown in Figure 1 . An open surgical biopsy was performed and the pathological examination showed histiocytic cell proliferation within a myxoid stroma, with inflammatory cells, myofibroblasts, and a few aggregates of large foamy cells. No specific diagnosis was made. A several-week course of high-dose methylprednisolone (2 mg/kg) was administered (with the putative diagnosis of an inflammatory or granulomatous disease), without any change in the retroperitoneal mass. Because the patient had no morbid symptoms, no further therapy was prescribed.
The patient was regularly seen at the outpatient clinic until 2002. In 2004, a pericardial effusion was observed incidentally. The work-up demonstrated inflammatory cells in the pericardial fluid but no specific diagnosis could be made. No clinical or radiological progression could be detected. The patient was lost to follow-up in 2005.
The patient was a schoolteacher and had 2 daughters in good health. Her personal family history was unremarkable. She had not been exposed to toxic agents and had not travelled extensively with contacts with animals. She did not smoke, drink alcohol, or take illicit drugs.
The patient was complaining of fatigue, constipation, night sweats, and difficulties with normal standing and walking, as well as of a swelling of the cheekbones. She was noticed by relatives to have a deep non-fluent voice.
At examination, the patient was not disoriented. Her vital signs were normal (blood pressure, pulse, and respiratory rate) and she was afebrile.
The heart sounds were faint, with no murmur; the lungs were clear. A large mass was palpable in the periumbilical region, with no obvious changes from previous examinations. There was no hepato-splenomegaly and there was no fluid in the abdomen. Neurological examination was suggestive of cerebellar ataxia; a hyperreflexia was observed in the upper and lower right limbs, with a clonus and Babinski sign.
The 2 supraorbital arches were deformed by an underlying hypertrophic bone structure (see Figures An MRI examination of the brain showed T2 hyperintense and T1 hypointense lesions in the pontine region, which were enhanced after gadolinium injection; these lesions were extending into the cerebellar peduncles and the cerebellar hemispheres ( Figure 5 ).
The skeletal workup consisted of a bone scan (increased uptake distal extremities) ( Figure 6 ) and regular X-rays (showing diffuse sclerotic changes of the distal extremities) ( Figures 7, 8) ; these sclerotic lesions were T1 and T2 hypointense signal on MRI ( Figure 9 ), with discrete hyperintense signal on T2 in the peripheral areas and under the periosteum (Figure 10 ).
At this point, the patient received a diagnosis of ErdheimChester disease, on the basis of the skeletal manifestations and the results of the bone biopsy.
The patient rapidly deteriorated neurologically and developed severe arterial hypertension considered to be related to retroperitoneal involvement of the renal arteries ( Figure 11 ). The patient died a few weeks after her admission; at post mortem examination, extensive histiocytic infiltration with large foamy cells was confirmed in the bones, the retroperitoneal region, and around the aorta and the renal arteries, as well as in the pericardium.
Discussion
Erdheim-Chester disease is a relatively rare illness, manifested by lesions within the peripheral skeleton. This is the feature that we wish to emphasize in the present case report. It is slightly more frequent in males (sex ratio 1.2-1.5) and is most often diagnosed during the sixth decade of life [1] [2] [3] [4] .
The bone lesions are bilateral and symmetric and are localized in the distal limb bones, mainly in the lower limbs. The lesions are most often localized at the diaphysis-metaphysis junction with no or little involvement of the epiphysis. Clinically, their manifestation consists of local pain and edema [5] [6] [7] . These aspects were present in our patient. Our patient presented with very significant periorbital lesions, which are quite common with this disease [8, 9] .
Lytic bone lesions have also been described as geodes with clear margins, but are less common. In case of coexisting sclerotic and lytic lesions, there is a possibility that ErdheimChester disease and eosinophilic granuloma coexist [10, 11] .
The technetium-99m bone scan often demonstrates hypercaptation, while in other "histiocytic" disorders this is not as constant [7] .
In extra-skeletal localizations of the disease, the retro-peritoneal involvement is by far the most frequent (30-50%); however, retroperitoneal infiltration is most often asymptomatic and is occasionally manifested by lower lumbar pain, problems with urination, and proteinuria with or without renal function impairment [1, 3, 4] .
The involvement of the central nervous is also relatively frequent and causes intracerebral or intramedullary lesions. The clinical manifestations are clearly dependent on the anatomical localization of the lesions. Infiltration of the pituitary stalk may cause diabetes insipidus [3, 5, 13] . MRI imaging usually shows increased contrast after gadolinium administration, which was not the case in our patient [12] [13] [14] .
Pulmonary infiltration is less common; it usually consists in a diffuse reticulo-nodular infiltration of both lungs, resulting in progressive dyspnea. This latter symptom may also be caused by myocardial or pericardial infiltration due to the disease, but can also be due to pleural effusions resulting from pleural infiltration by the disease [15] . Other sites of the disease are occasionally seen: skin, liver, spleen, or isolated mesenteric infiltration. Recent reviews confirm the usual presentation of Erdheim-Chester disease as outlined here [16] [17] [18] .
In our case, the initial presentation of the Erdheim-Chester disease was a retro-peritoneal mass; however, although that kind of presentation is classical, the correct diagnosis had not been made. The patient remained stable in terms of retroperitoneal mass for many years. A pericardial effusion was investigated, but no specific diagnosis was made (inflammatory nonspecific cells in the pericardial effusion).
Six years after initial presentation, the patient developed serious neurological symptoms, manifested as cerebellar and pyramidal involvement caused by infiltration of the pons and cerebellum. At the same time, peri-orbital infiltration was noticed and confirmed by histology. Although not very symptomatic, the patient had local pain and edema, and involvement of the distal extremities was radiologically demonstrated. Finally, extensive infiltration of the retroperitoneal space led to a compression of the renal arteries, resulting in severe arterial hypertension.
From the pathological point of view, Erdheim-Chester disease is due to a proliferation of foamy histiocytes causing granulomatous and fibrotic changes in various tissues, mainly the retroperitoneal space and skeleton. This disease can be distinguished from histiocytosis X (Langerhans cells) on the basis of immunochemistry showing the presence of protein S-100, which is characteristic of Langerhans cells [1, 2, 5] .
Erdheim-Chester disease is a multi-system illness with predominantly bone, retroperitoneal, and peri-orbital involvement, which was clearly illustrated in our patient. The course of the disease is highly variable, but long delays between the successive progressions are common, as seen in our case and can vary from months to years (more than 15) [1, 4] .
The overall prognosis of Erdheim-Chester disease depends on the severity of the extra-skeletal lesions, such as pericardial tamponade, neurological involvement, and retroperitoneal infiltration leading to renal failure or sepsis [1, 16, 17] . The usual duration of survival varies from a few months (3 months) to many years (10 years).
Conclusions
There is at present no known therapy for Erdheim-Chester disease. Corticosteroids are often used, as in our patient, but there is no evidence for their efficacy. Cytostatic chemotherapy, extensive surgery, and radiation therapy have been used without success [16, 17] .
Recently, there has been some evidence for a role of the oncogenetic BRAF V600E mutation in this histiocytosis pathogenesis [19, 20] . These findings might suggest new avenues for the mechanisms responsible for the disease and potential therapeutic possibilities.
Erdheim-Chester disease is a systemic "histiocytosis" caused by non-Langerhans cells and typically foamy histiocytes, mainly involving bones and the retroperitoneal space. Although the course may be protracted, the overall prognosis is relatively poor.
